ADTX

Q: What is the price of ADiTx Therapeutics (ADTX) today?

The current price of ADiTx Therapeutics (ADTX) is $ 0.45, representing a -99.98% gain over the past year. The stock began the year trading around $ 0.83 and is currently priced at $ 0.45. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does ADiTx Therapeutics (ADTX) pay dividends?

ADiTx Therapeutics (ADTX) did not pay dividends over the past year.

ADiTx Therapeutics Inc.

Price

$ 0.45

return (12m)

-99.98%

p/e

-0.03

p/bv

0.27

DIVIDEND YIELD

0.00%

ADTX price

ADTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ADTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-72.41%

3 months

-92.46%

1 year

-99.98%

2 years

-100.00%

5 years

-100.00%

10 years

0.00%

Fundamentals ADTX

review the fundamentals of ADiTx Therapeutics shares

P/E

-0.03

Sector: -3.96 Industry: -3.96

P/S (PSR)

Sector: -3.88 Industry: -3.88

P/BV

0.27

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-252.54%

Sector: -61.39% Industry: -61.39%

ROE

-1,056.20%

Sector: -60.71% Industry: -60.71%

ROIC

-99.09%

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

0.00%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

0.00%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

0.00%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

-0.03

Sector: -3.80 Industry: -3.80

EV/EBIT

-0.03

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

0.06

Sector: 1.38 Industry: 1.38

BVPS

1.98

Sector: 1.89 Industry: 1.89

EPS

-20.86

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.24

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.76

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-2.09%

Sector: - Industry: -

Fundamentals ADTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ADTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ADiTx Therapeutics

ADiTx Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

9 years

Founded: 2017

2020

Time since IPO - 6 years

6

Employees

ADiTx Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.06 Million, with shareholders equity totaling $3.95 Millions.

The company employs approximately 6 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ADiTx Therapeutics Inc. reported $- in revenue, generating net income of $-41.72 Millions.

Key financial metrics include a P/E ratio of -0.03, a price-to-book (P/B) ratio of 0.27, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADTX.

Market cap

$ 1.06 Million

Net worth

$ 3.95 Millions

$ 3,950,000.00

Assets

$ 16.52 Millions

$ 16,520,000.00

Total Shares Outstanding

2.00 Millions

2,000,000

Average Daily Trading Volume

$ 510.74 Thousand

$ 510,735.84

Sector

Health Care

Industry

Biotechnology

ADTX

ADTX revenue and profits

Financial Results ADTX

DRAG THE FRAME TO SEE MORE DATA

ADTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 863.42 24,78% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 211.83 59,44% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 238.67 59,39% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 27.19 32,32% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 208.42 26,42% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 117.90 59,80% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 201.21 51,51% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 863.42 24,78% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 211.83 59,44% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 238.67 59,39% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 27.19 32,32% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 208.42 26,42% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 117.90 59,80% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 201.21 51,51% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

Frequently Asked Questions

What is the price of ADiTx Therapeutics (ADTX) today?

The current price of ADiTx Therapeutics (ADTX) is $ 0.45, representing a -99.98% gain over the past year. The stock began the year trading around $ 0.83 and is currently priced at $ 0.45. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does ADiTx Therapeutics (ADTX) pay dividends?

ADiTx Therapeutics (ADTX) did not pay dividends over the past year.

Is ADiTx Therapeutics (ADTX) a good investment?

ADiTx Therapeutics (ADTX) is currently trading at $ 0.45 with a P/E ratio of -0.03%. This represents a -50,063,995% premium compared to its historical average P/E. Over the past year, the stock has gained -99.98 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -99.98%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ADiTx Therapeutics (ADTX) stock?

You can buy ADiTx Therapeutics (ADTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ADTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of ADiTx Therapeutics (ADTX) yield today?

Over the past month, ADiTx Therapeutics (ADTX) has returned -72.41% — -99.98% over the past year, and -100.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of ADiTx Therapeutics (ADTX) today at the current price of $ 0.45 your total investment would be $ 44.70.

Based on historical performance, the investment would have grown to approximately:

$ 0.008940 after 1 year
$ 0.00 after 5 years
$ 44.70 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ADTX

ADiTx Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ADTX

review the fundamentals of ADiTx Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ADiTx Therapeutics

ADiTx Therapeutics Inc.

United States

9 years

2020

6

PROFIT X PRICE ADTX

Financial Results ADTX

ADTX cash flow

Asset, Revenue and Profit Growth - ADTX

ADTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions